Profile picture

Professor Shenghua Zhou

The Second Xiangya Hospital of Central South University, Changsha (China)
Follow
Logo ESC

Contributor content

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)
Presentation
Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)
Read more

ESC 365 is supported by

novartis Explore sponsored resources